This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Stocks in Motion

Updated from 2:15 p.m. EDT

Shares of eResearch Technology (ERES) were among the worst-performing health and pharmaceutical stocks Thursday, falling 16.4% after the company posted third-quarter earnings that fell below Wall Street expectations and warned that fourth-quarter earnings and sales would be below expectations as well.

The supplier of technology used by biotech companies earned 13 cents a share during the third quarter on sales of $28 million. Analysts polled by Thomson First Call were expecting earnings of 14 cents a share on sales of $27.3 million. Looking ahead, eResearch forecast a fourth-quarter profit of 11 cents to 15 cents a share on sales of $26 million to $30 million. Analysts had been expecting earnings of 16 cents a share on sales of $31.5 million. Shares traded down $2.23 to $11.36.

Align Technology (ALGN - Get Report) fell 33.2% after the company delivered in-line third-quarter earnings results but turned in weaker-than-expected sales results. The maker of teeth-straightening products posted pro forma earnings of 7 cents a share on sales of $45.8 million. Analysts were expecting earnings of 7 cents a share on sales of $47.3 million. A year ago, Align earned 2 cents a share on sales of $34 million. Shares of Align traded down $4.92 to $9.90.

Shares of Apria Healthcare (AHG) fell 4.3% after the company posted mixed third-quarter financial results and lowered its full-year earnings growth projections. The home health care company earned 60 cents a share during the third quarter on sales of $364.6 million. Analysts were expecting earnings of 59 cents a share on sales of $366.5 million. Looking ahead, Apria said that it believes it will turn in full-year earnings growth of 6% to 8%. Previously, the company said that it would grow earnings by 7% to 9%. Shares traded down $1.25 to $27.90.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
PFE $35.01 0.00%
ALGN $54.20 0.00%
AMGN $165.97 0.00%
GNSG $0.40 0.00%
AAPL $127.60 0.00%

Markets

DOW 18,034.93 +208.63 1.17%
S&P 500 2,100.40 +19.22 0.92%
NASDAQ 4,994.6020 +62.7870 1.27%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs